Pulmonary arterial hypertension trials in China

In China 44 Also abroad 305

44 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Where
Fuzhou, Jinan, Nanjing, Xiamen
Age
18 years to 85 years
People
750 worldwide
Run by
Pulnovo Medical, Inc.
See details and how to joinNCT07214376
Phase 3Taking people
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Where
Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
Age
2 years and over
People
280 worldwide
Run by
Actelion
See details and how to joinNCT05179876 · EU 2023-506791-27-00
No phaseTaking people
Vasopressor Agents in Pulmonary Hypertension Crisis
Where
Beijing, Guangzhou, Wuhan
Age
18 years and over
People
75
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07667829
No phaseNot yet taking people in China
CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support
Where
Beijing
Age
18 years and over
People
60
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07902011
No phaseTaking people
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
Where
Beijing
Age
18 years and over
People
480
Run by
Chinese Pulmonary Vascular Disease Research Group
See details and how to joinNCT05595200
No phaseTaking people
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
Where
Beijing
Age
18 years and over
People
2,000
Run by
Chinese Pulmonary Vascular Disease Research Group
See details and how to joinNCT05566002
Phase 3Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Beijing, Changsha, Guangzhou, Shanghai
Age
18 years and over
People
1,000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
No phaseTaking people
PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
Where
Fuzhou
Age
18 years and over
People
1,000
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07131241
No phaseTaking people
PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension
Where
Beijing
Age
18 years and over
People
1,500
Run by
Chinese Pulmonary Vascular Disease Research Group
See details and how to joinNCT07852403
No phaseTaking people
Safety and Efficacy of Balloon Pulmonary Angioplasty in China
Where
Beijing
Age
18 years and over
People
1,000
Run by
Chinese Pulmonary Vascular Disease Research Group
See details and how to joinNCT04206852
Phase 1/2Taking people
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Where
Beijing
Age
10 years to 65 years
People
45
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06947460
Phase 1/2Taking people
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
Where
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Hangzhou, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Shanghai, Shenyang, Tianjin, Wuhan, Xiamen, Xuzhou, Zhengzhou
Age
18 years to 75 years
People
120
Run by
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
See details and how to joinNCT07593027
Early phase 1Taking people
Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study
Where
Xiamen
Age
18 years to 80 years
People
60
Run by
Xiamen Cardiovascular Hospital, Xiamen University
See details and how to joinNCT07662655
No phaseTaking people
Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
Where
Beijing, Guangzhou, Kunming, Shanghai
People
5,000
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07653958
No phaseTaking people
Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension
Where
Guangzhou
Age
18 years to 75 years
People
120
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT07604805
No phaseTaking people
Close Loop Smart Weaning for INO With PPHN
Where
Shanghai
People
30
Run by
Children's Hospital of Fudan University
See details and how to joinNCT06832163
No phaseTaking people
Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes
Where
Guangzhou
Age
Up to 18 years
People
450
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT07495774
Phase 1Taking people
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
Where
Beijing
Age
18 years and over
People
72
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06554301
Phase 1/2Taking people
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Where
Beijing
Age
6 years to 65 years
People
45
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06947473
No phaseNot yet taking people in China
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography
Where
Anshan, Beijing, Changchun, Chaoyang, Chengdu, Chongqing, Dalian, Harbin, Huludao, Liaoyang, Qingdao, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Wuhan, Xi’an, Xiangyang, Xianyang, Zhengzhou
Age
18 years to 79 years
People
2,640
Run by
First Hospital of China Medical University
See details and how to joinNCT07292896
No phaseTaking people
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
Where
Beijing
Age
3 months to 85 years
People
700
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT05372263
No phaseTaking people
Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
Where
Beijing
Age
18 years and over
People
150
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07184814
No phaseTaking people
Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
Where
Shanghai
Age
18 years to 75 years
People
104
Run by
RenJi Hospital
See details and how to joinNCT07149935
No phaseTaking people
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
Where
Guangzhou
Age
Up to 7 days
People
120
Run by
Lee's Pharmaceutical Limited
See details and how to joinNCT07099144
No phaseTaking people
Comparison of Sequential to Initial Combination Therapy in PAH
Where
Hangzhou
Age
18 years to 80 years
People
376
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06968962